Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Atossa Genetics stock

Learn how to easily invest in Atossa Genetics stock.

Atossa Genetics Inc is a biotechnology business based in the US. Atossa Genetics shares (ATOS) are listed on the NASDAQ and all prices are listed in US Dollars. Atossa Genetics employs 6 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Atossa Genetics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ATOS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Atossa Genetics stock price (NASDAQ: ATOS)

Use our graph to track the performance of ATOS stocks over time.

Atossa Genetics shares at a glance

Information last updated 2022-09-26.
Latest market close$0.83
52-week range$0.81 - $3.44
50-day moving average $0.97
200-day moving average $1.19
Wall St. target price$5.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.17

Buy Atossa Genetics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Atossa Genetics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Atossa Genetics price performance over time

Historical closes compared with the close of $0.8333 from 2022-09-30

1 week (2022-09-23) 1.62%
1 month (2022-09-02) -8.43%
3 months (2022-07-01) -17.50%
6 months (2022-03-30) -36.87%
1 year (2021-09-28) N/A
2 years (2020-10-02) -65.28%
3 years (2019-10-02) 1.75
5 years (2017-10-02) 54.31%

Atossa Genetics financials

Gross profit TTM $0
Return on assets TTM -9.53%
Return on equity TTM -15.66%
Profit margin 0%
Book value $1.02
Market capitalisation $104.4 million

TTM: trailing 12 months

Atossa Genetics share dividends

We're not expecting Atossa Genetics to pay a dividend over the next 12 months.

Have Atossa Genetics's shares ever split?

Atossa Genetics's shares were split on a 1:12 basis on 19 April 2018. So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Atossa Genetics shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Atossa Genetics shares which in turn could have impacted Atossa Genetics's share price.

Atossa Genetics share price volatility

Over the last 12 months, Atossa Genetics's shares have ranged in value from as little as $0.81 up to $3.44. A popular way to gauge a stock's volatility is its "beta".

ATOS.US volatility(beta: 1.67)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Atossa Genetics's is 1.6664. This would suggest that Atossa Genetics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Atossa Genetics overview

Atossa Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patients; AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc.

Frequently asked questions

What percentage of Atossa Genetics is owned by insiders or institutions?
Currently 0.041% of Atossa Genetics shares are held by insiders and 25.027% by institutions.
How many people work for Atossa Genetics?
Latest data suggests 6 work at Atossa Genetics.
When does the fiscal year end for Atossa Genetics?
Atossa Genetics's fiscal year ends in December.
Where is Atossa Genetics based?
Atossa Genetics's address is: 107 Spring Street, Seattle, WA, United States, 98104
What is Atossa Genetics's ISIN number?
Atossa Genetics's international securities identification number is: US04962H5063
What is Atossa Genetics's CUSIP number?
Atossa Genetics's Committee on Uniform Securities Identification Procedures number is: 04962H100

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site